Enriched Environment Confers Resistance to 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine and Cocaine: Involvement of Dopamine Transporter and Trophic Factors

Journal of Neuroscience

Volumn 23, Issue 35, 2003, Pages 10999-11007

  Bezard, Erwan ^a   Dovero, Sandra ^a   Belin, David ^b   Duconger, Sophie ^b   Jackson Lewis, Vernice ^c   Przedborski, Serge ^c   Piazza, Pier Vincenzo ^b   Gross, Christian E ^a   Jaber, Mohamed ^d  

^a CNRS   (France)

^b INSTITUT FRANÇOIS MAGENDIE   (France)

^c Howard Hughes Medical Institute   (United States)

^d UNIVERSITÉ DE POITIERS   (France)

Author keywords

BDNF; C fos; Dopamine transporter; Drug of abuse; Environmental enrichment; Parkinson's disease; Tyrosine hydroxylase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BRAIN DERIVED NEUROTROPHIC FACTOR; COCAINE; DOPAMINE TRANSPORTER; MESSENGER RNA; NEUROTOXIN; PROTEIN C FOS; PSYCHOSTIMULANT AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; DRUG DEPENDENCE; ENVIRONMENT; EXPERIENCE; IN SITU HYBRIDIZATION; LIFE; LOCOMOTION; MOUSE; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0346749428     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-35-10999.2003     Document Type: Article

References (75)

1. Badiani A, Browman KE, Robinson TE (1995) Influence of novel versus home environments on sensitization to the psychomotor stimulant effects of cocaine and amphetamine. Brain Res 674:291-298.
2. Bezard E, Dovero S, Bioulac B, Gross C (1997) Effect of different schedules of MPTP administration on dopaminergic neurodegeneration in mice. Exp Neurol 148:288-292.
3. Bezard E, Gross CE, Fournier MC, Dovero S, Bloch B, Jaber M (1999) Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter. Exp Neurol 155:268-273.
4. Bezard E, Ravenscroft P, Gross CE, Crossman AR, Brotchie JM (2001a) Up-regulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine monkeys, Neurobiol Dis 8:343-350.
5. Bezard E, Boraud T, Chalon S, Brotchie JM, Guilloteau D, Gross CE (2001b) Pallidal border cells: an anatomical and electrophysiological study in the MPTP-treated monkey. Neuroscience 103:119-125.
6. Bezard E, Dovero S, Prunier C, Ravenscroft P, Chalon S, Guilloteau D, Bioulac B, Brotchie JM, Gross CE (2001c) Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease. J Neurosci 21:6853-6861.
7. Bjorklund A, Lindvall O (2000) Parkinson disease gene therapy moves toward the clinic. Nat Med 6:1207-1208.
8. Black JE, Sirevaag AM, Wallace CS, Savin MH, Greenough WT (1989) Effects of complex experience on somatic growth and organ development in rats. Dev Psychobiol 22:727-752.
9. Cabib S, Puglisi-Allegra S, Ventura R (2002) The contribution of comparative studies in inbred strains of mice to the understanding of the hyperactive phenotype. Behav Brain Res 130:103-109.
10. Cenci MA, Bjorklund A (1993) Transection of corticostriatal afferents reduces amphetamine- and apomorphine-induced striatal fos expression and turning behaviour in unilaterally 6-hydroxydopamine-lesioned rats. Eur J Neurosci 5:1062-1070.
11. Cohen AD, Tillerson JL, Smith AD, Schallert T, Zigmond MJ (2003) Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. J Neurochem 85:299-305.
12. Dal Toso R, Sommer B, Ewert M, Herb A, Pritchett DB, Bach A, Shivers BD, Seeburg PH (1989) The dopamine D2 receptor: two molecular forms generated by alternative splicing. EMBO J 8:4025-4034.
13. Dawson TM, Dawson VL (2002) Neuroprotective and neurorestorative strategies for Parkinson's disease. Nat Neurosci [Suppl] 5:1058-1061.
14. Day HE, Badiani A, Uslaner JM, Oates MM, Vittoz NM, Robinson TE, Watson SJ, Akil H (2001) Environmental novelty differentially affects c-fos mRNA expression induced by amphetamine or cocaine in subregions of the bed nucleus of the stria terminalis and amygdala. J Neurosci 21:732-740.
15. Dearry A, Gingrich JA, Falardeau P, Fremeau Jr RT, Bates MD, Caron MG (1990) Molecular cloning and expression of the gene for a human DI dopamine receptor. Nature 347:72-76.
16. Deroche-Gamonet V, Sillaber I, Aouizerate B, Izawa R, Jaber M, Ghozland S, Kellendonk C, Le Moal M, Spanagel R, Schutz G, Tronche F, Piazza PV (2003) The glucocorticoid receptor as a potential target to reduce cocaine abuse. J Neurosci 23:4785-4790.
17. Fernagut PO, Diguet E, Jaber M, Tison F (2002) Prolonged elevated dopamine levels increase striatal neurodegeneration: evidence from DAT knock-out mice. Eur J Neurosci 15:2053-2056.
18. Fiala BA, loyce JN, Greenough WT (1978) Environmental complexity modulates growth of granule cell dendrites in developing but not adult hippocampus of rats. Exp Neurol 59:372-383.
19. Franldin KB, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Orlando, FL: Academic.
20. Gainetdinov RR, Fumagalli F, Jones SR, Caron MG (1997) Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter. J Neurochem 69:1322-1325.
21. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG (1999) Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283:397-401.
22. Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L, Russell D, Martin D, Lapchak PA, Collins F, Hoffer BJ, Gerhardt GA (1996) Functional recovery in parkinsonian monkey treated with GDNF. Nature 380:252-255.
23. German DC, Nelson EL, Liang CL, Speciale SG, Sinton CM, Sonsalla PK (1996) The neurotoxin MPTP causes degeneration of specific nucleus A8, A9, and A 10 dopaminergic neurons in the mouse. Neurodegeneration 5:299-312.
24. Giros B, Caron MG (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14:43-49.
25. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612.
26. Gomez-Pinilla F, Dao L, So V (1997) Physical exercise induces FGF-2 and its mRNA in the hippocampus. Brain Res 764:1-8.
27. Gonon F, Burie JB, Jaber M, Benoit-Marand M, Dumartin B, Bloch B (2000) Geometry and kinetics of dopaminergic transmission in the rat striatum and in mice lacking the dopamine transporter. Prog Brain Res 125:291-302.
28. Green TA, Gehrke BJ, Bardo MT (2002) Environmental enrichment decreases intravenous amphetamine self-administration in rats: dose-response functions for fixed- and progressive-ratio schedules. Psychopharmacology (Berl) 162:373-378.
29. Gross CE, Ravenscroft P, Dovero S, Jaber M, Bioulac B, Bezard E (2003) Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice. J Neurochem 84:1246-1255.
30. Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P (2001) BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 411:86-89.
31. Guilloteau D, Emond P, Baulieu JL, Garreau L, Frangin Y, Pourcelot L, Mauclaire L, Besnard JC, Chalon S (1998) Exploration of the dopamine transporter: in vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane derivative (E)-N-(3-iodoprop-2-enyl)-2β -carbomethoxy-3β-(4′-methylphenyl) nortropane (PE2I). Nucl Med Biol 25:331-337.
32. Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sorensen FB, Vesterby A, West MJ (1988) The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96:857-881.
33. Honig LS, Rosenberg RN (2000) Apoptosis and neurologic disease. Am J Med 108:317-330.
34. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230-232.
35. Jaber M, Cador M Dumartin B, Normand E, Stinus L, Bloch B (1995) Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons. Neuroscience 65:1041-1050.
36. Jaber M, Robinson SW, Missale C, Caron MG (1996) Dopamine receptors and brain function. Neuropharmacology 35:1503-1519.
37. Jaber M, Jones S, Giros B, Caron MG (1997) The dopamine transporter: a crucial component regulating dopamine transmission. Mov Disord 12:629-633.
38. Jaber M, Dumartin B, Sagné C, Haycock JW, Roubert C, Giros B, Bloch B, Caron MG (1999) Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. Eur J Neurosci 11:3499-3511.
39. Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S (1995) Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 4:257-269.
40. Jackson-Lewis V, Vila M, Djaldetti R, Guegan C, Liberatore G, Liu J, O'Malley KL, Burke RE, Przedborski S (2000) Developmental cell death in dopaminergic neurons of the substantia nigra of mice. J Comp Neurol 424:476-488.
41. Johansson B, Lindstrom K, Fredholm BB (1994) Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience 59:837-849.
42. Johansson BB (1996) Functional outcome in rats transferred to an enriched environment 15 days after focal brain ischemia. Stroke 27:324-326.
43. Kelleher RT, Morse WH (1968) Determinants of the specificity of behavioral effects of drugs. Ergeb Physiol 60:1-56.
44. Kempermann G, Kuhn HG, Gage FH (1997) More hippocampal neurons in adult mice living in an enriched environment. Nature 386:493-495.
45. Kleim JA, Vij K, Ballard DH, Greenough WT (1997) Learning-dependent synaptic modifications in the cerebellar cortex of the adult rat persist for at least four weeks. J Neurosci 17:717-721.
46. Kolb B, Gibb R (1991) Environmental enrichment and cortical injury: behavioral and anatomical consequences of frontal cortex lesions. Cereb Cortex 1:189-198.
47. Lieb K, Andersen C, Lazarov N, Zienecke RR, Urban I, Reisert I, Pilgrim C (1996) Pre- and postnatal development of dopaminergic neuron numbers in the male and female mouse midbrain. Brain Res Dev Brain Res 94:37-43.
48. Lothman EW, Bertram III EH (1993) Epileptogenic effects of status epilepticus. Epilepsia 34 [Suppl 1]:S59-S70.
49. Mayer RA, Kindt MV, Heikkila RE (1986) Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport. J Neurochem 47:1073-1079.
50. Meissner W, Bioulac B, Gross CE, Bezard E (2003) Within-basal ganglia compensatory mechanisms after striatal dopaminergic homeostasis breakdown. Neurobiol Dis 13:46-54.
51. Miller RG (1981) Simultaneous statistical inference, Ed 2. New York: Springer.
52. Nawa H, Kotani H, Nakanishi S (1984) Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing. Nature 312:729-734.
53. Neeper SA, Gomez-Pinilla F, Choi J, Cotman C (1995) Exercise and brain neurotrophins. Nature 373:109.
54. Nesse RM, Berridge KC (1997) Psychoactive drug use in evolutionary perspective. Science 278:63-66.
55. Nestler EJ (2001) Molecular basis of long term plasticity underlying addiction. Nat Rev Neurosci 2:119-128.
56. Nestler EJ, Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278:58-63.
57. Nilsson M, Perfilieva E, Johansson U, Orwar O, Eriksson PS. (1999) Enriched environment increases neurogenesis in the adult rat dentate gyrus and improves spatial memory. J Neurobiol 39:569-578.
58. Piazza PV, Le Moal M (1998) The role of stress in drug self-administration. Trends Pharmacol Sci 19:67-74.
59. Przedborski S, Kostic V, Jackson-Lewis V, Naini AB, Simonetti S, Fahn S, Carlson E, Epstein CJ, Cadet JL (1992) Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J Neurosci 12:1658-1667.
60. Rampon C, Tang YP, Goodhouse J, Shimizu E, Kyin M, Tsien JZ (2000) Enrichment induces structural changes and recovery from nonspatial memory deficits in CA1 NMDAR1-knockout mice. Nat Neurosci 3:238-244.
61. Rice D, Barone Jr S (2000) Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 108 [Suppl 3]:511-533.
62. Rosenzweig MR, Bennett EL (1996) Psychobiology of plasticity: effects of training and experience on brain and behavior. Behav Brain Res 78:57-65.
63. Saito S, Kobayashi S, Ohashi Y, Igarashi M, Komiya Y, Ando S (1994) Decreased synaptic density in aged brains and its prevention by rearing under enriched environment as revealed by synaptophysin contents. J Neurosci Res 39:57-62.
64. Spielewoy C, Gonon F, Roubert C, Fauchey V, Jaber M, Caron MG, Roques BP, Hamon M, Betancur C, Maldonado R, Giros B (2000) Increased rewarding properties of morphine in dopamine-transporter knock-out mice. Eur J Neurosci 12:1827-1837.
65. Tang F, Costa E, Schwartz JP (1983) Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2 to 3 weeks. Proc Natl Acad Sci USA 80:3841-3844.
66. Theoret H, Boire D, Herbin M, Ptito M (1999) Stereological evaluation of substantia nigra cell number in normal and hemispherectomized monkeys. Brain Res 835:354-359.
67. Tillerson JL, Cohen AD, Philhower J, Miller GW, Zigmond MJ, Schallert T (2001) Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J Neurosci 21:4427-4435.
68. Tillerson JL, Cohen AD, Caudle WM, Zigmond MJ, Schallert T, Miller GW (2002) Forced nonuse in unilateral parkinsonian rats exacerbates injury. J Neurosci 22:6790-6799.
69. Van Dellen A, Blakemore C, Deacon R, York D, Hannan AJ (2000) Delaying the onset of Huntington's in mice. Nature 404:721-722.
70. Walsh RN, Budtz-Olsen OE, Penny JE, Cummins RA (1969) The effects of environmental complexity on the histology of the rat hippocampus. J Comp Neurol 137:361-366.
71. West MJ, Gundersen HJ (1990) Unbiased stereological estimation of the number of neurons in the human hippocampus. J Comp Neurol 296:1-22.
72. Wikler WA (1948) Recent progress in research on the neurophysical basis of morphine addiction. Am J Psychiatry 105:328-338.
73. Wong JY, Liberatore GT, Donnan GA, Howells DW (1997) Expression of brain-derived neurotrophic factor and TrkB neurotrophin receptors after striatal injury in the mouse. Exp Neurol 148:83-91.
74. Young D, Lawlor PA, Leone P, Dragunow M, During MJ (1999) Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat Med 5:448-453.
75. Zigmond MJ, Stricker EM (1985) Adaptive properties of monoaminergic neurons. In: Handbook of neurochemistry (Lajtha A, ed), pp 87-102. New York: Plenum.